Model Number M00565590 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Perforation (2001)
|
Event Date 11/29/2023 |
Event Type
Injury
|
Event Description
|
It was reported to boston scientific corporation that a wallstent enteral uncovered stent was to be implanted in the intestinal tract to treat a malignant 4 cm intestinal obstruction during a stent implantation procedure performed on (b)(6) 2023.The patient's anatomy was moderately tortuous.During the procedure, the burrs at the tip of the stent caused intestinal perforation.The patient was sent for surgery to address the perforation and remove the stent.The procedure was completed with another wallstent enteral uncovered stent.The patient's condition after the procedure was reported to be stable.
|
|
Manufacturer Narrative
|
Block h6: imdrf patient code e2114 captures the reportable patient complication of perforation.Imdrf impact code f19 captures the surgical procedure performed to address the perforation.
|
|
Manufacturer Narrative
|
Block h6: imdrf patient code e2114 captures the reportable patient complication of perforation.Imdrf impact code f19 captures the surgical procedure performed to address the perforation.Block h10: the wallstent enteral uncovered stent delivery system was returned for analysis.The stent was not received for analysis.Visual inspection found that the outer sheath and the inner sheath were kinked.No other damages were noted with the delivery system.Product analysis confirmed the reported events of perforation and surgical intervention as known potential adverse events associated with the use of the device and are documented in the labeling (including both short- or long-term known complications or adverse reactions).Additionally, the additional investigation findings of outer sheath and inner sheath kinking were most likely due to procedural factors such as lesion characteristics, the handling of the device, and the technique used by the physician (force applied), which could have resulted in the damages noted to the device.Therefore, a review and analysis of all available information indicated that the most probable cause is known inherent risk of device.A product labeling review identified that the device was used per the instructions for use (ifu)/product label.
|
|
Event Description
|
It was reported to boston scientific corporation that a wallstent enteral uncovered stent was to be implanted in the intestinal tract to treat a malignant 4 cm intestinal obstruction during a stent implantation procedure performed on (b)(6) 2023.The patient's anatomy was moderately tortuous.During the procedure, the burrs at the tip of the stent caused intestinal perforation.The patient was sent for surgery to address the perforation and remove the stent.The procedure was completed with another wallstent enteral uncovered stent.The patient's condition after the procedure was reported to be stable.
|
|
Search Alerts/Recalls
|